Fig. 1From: Optical coherence tomography biomarkers as outcome predictors to guide dexamethasone implant use in patients with iERM: a randomized controlled trialIntravitreous concentrations of sCD163 and sCD14 in eyes with and without HRF. (A) Intravitreous concentration sCD163 in eyes with or without HFP. *P = 0.036, Z=-2.09. (B) Intravitreous concentration of sCD14 in eyes with or without HRF. nsP = 0.313, Z=-1.01Back to article page